Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer

Table 8

Comparison of the incidence of adverse reactions between the two groups (n).

Adverse reactions	Control group				Observation group				value	χ^2
	I	II	III	IV	I	II	III	IV
Nausea and vomiting	16	8	2	0	7	2	0	0	0.005	5.123
Renal injury	5	0	0	0	1	0	0	0	0.041	2.654
Liver injury	6	1	0	0	2	0	0	0	0.036	4.659
Neurovirulence	4	0	0	0	3	0	0	0	0.157	1.054